Zyphra Release Zamba2-VL: Hybrid Mamba2–Transformer Vision-Language Models That Cut Time-to-First-Token by About an Order of Magnitude

Zyphra has released Zamba2-VL, a family of open vision-language models. The release covers three sizes: 1.2B, 2.7B, and 7B parameters. Each model is built on the Zamba2 hybrid SSM–Transformer backbone. Vision-language models (VLMs) read images and text together. They answer questions about charts, documents, and photos. Most open VLMs use a dense Transformer as the…

Read Full News

RAG-Anything Tutorial: Build a Multimodal Retrieval Pipeline for Text, Tables, Equations, and Images in Colab

print(“\n[5/10] Creating a synthetic multimodal report…”) monthly_data = pd.DataFrame( { “Month”: [“Jan”, “Feb”, “Mar”, “Apr”, “May”, “Jun”], “Query Volume”: [1200, 1700, 2100, 2600, 3300, 4100], “Hybrid Accuracy”: [0.71, 0.74, 0.79, 0.83, 0.87, 0.91], “Average Latency ms”: [980, 920, 850, 790, 760, 730], } ) table_md = monthly_data.to_markdown(index=False) plt.figure(figsize=(8, 4.8)) plt.plot(monthly_data[“Month”], monthly_data[“Query Volume”], marker=”o”, label=”Query Volume”)…

Read Full News
How Polymarket Reportedly Used Pretend Profitable Bets to Drive Viral Progress

How Polymarket Reportedly Used Pretend Profitable Bets to Drive Viral Progress

The identical bets that gained hundreds of thousands within the promotional clips incurred losses for merchants in actuality. Latest findings by The Wall Road Journal (WSJ) have revealed stunning particulars concerning the promotional content material of the prediction platform, Polymarket. As reported, nearly all of the profitable bets that drove the platform’s viral progress had…

Read Full News

B.C. plywood manufacturer says it cannot absorb 50% tariff cost as deadline looms

A Richmond plywood manufacturer is concerned about what Wednesday is going to bring for his business. Canada-U.S. Trade Minister Dominic LeBlanc met with U.S. Trade Representative Jamieson Greer and U.S. Commerce Secretary Howard Lutnick as officials race against the clock to secure a new trade deal before new 50-per-cent tariffs take effect Wednesday. The duties will impact…

Read Full News

Cancer patients suffer as 40 drugs’ approvals remain pending

Cancer treatment drug in Provo, Utah, US, April 8, 2025. — Reuters Pembrolizumab among 40 medicines awaiting approval.  Patients increasingly rely on costly informal imports.  Minister says government pursuing final approvals. ISLAMABAD: A young woman battling triple-negative breast cancer has been unable to obtain the life-saving immunotherapy drug despite its registration in Pakistan because it…

Read Full News